ABBV AbbVie Inc. | US00287Y1091
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 72.838.594.540 | 67.267.945.920 | 8.28% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 16,29 | 14,13 | 15.34% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 24 | 27 | 11.11% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |